Stemline Therapeutics

ELZONRIS

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / ELZONRIS – J9269

Manufacturer:

Stemline Therapeutics

Name:

ELZONRIS

HCPCS Code Descriptor:

Injection, tagraxofusp-erzs, 10 micrograms

Category:

J Code

HCPCS:

J9269

NDC(s):

72187-0401-01

Primary Type:

Oncology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

ELZONRIS is an Oncology drug manufactured by Stemline Therapeutics and administered via the Intravenous route of administration. The J Code: J9269 is aligned to the drug ELZONRIS.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

10/1/19

HCPCS Effective Date:

10/1/19

HCPCS Short Description:

Inj. tagraxofusp-erzs 10 mcg

Billing and Coding Guide:

https://www.elzonris.com/hcp/content/documents/Coding_and_Billing_Guide.pdf

Patient Assistance:

https://elzonris.com/hcp/stemline-arc-summary/

ELZONRIS - J9269